Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
400 participants
OBSERVATIONAL
2024-07-31
2029-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard-risk patients who underwent carotid intervention
Symptomatic or asymptomatic patients with a discrete lesion located in the internal carotid artery (ICA) with or without involvement of the contiguous common carotid artery (CCA), who underwent carotid artery revascularization.
Transcarotid Artery Revascularization (TCAR)
Carotid artery revascularization treated with the FDA-cleared ENROUTE Transcarotid NPS in conjunction with the FDA-approved ENROUTE Transcarotid Stent
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcarotid Artery Revascularization (TCAR)
Carotid artery revascularization treated with the FDA-cleared ENROUTE Transcarotid NPS in conjunction with the FDA-approved ENROUTE Transcarotid Stent
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to provide informed consent
Exclusion Criteria
18 Years
79 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Silk Road Medical
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Meghan Dermody, MD
Role: PRINCIPAL_INVESTIGATOR
Lancaster General Hospital
Jeffrey Jim, MD
Role: PRINCIPAL_INVESTIGATOR
Abbott Northwestern Minneapolis Heart Institute Foundation
Marc Schermerhorn, MD
Role: PRINCIPAL_INVESTIGATOR
Beth Israel Deaconess Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Valley Vascular Consultants
Huntsville, Alabama, United States
HonorHealth
Scottsdale, Arizona, United States
Pima Heart & Vascular
Tucson, Arizona, United States
University of California, San Diego (UCSD)
La Jolla, California, United States
Sharp Grossmont
La Mesa, California, United States
Morton Plant Hospital
Clearwater, Florida, United States
Delray Medical Center
Delray Beach, Florida, United States
Mount Sinai Medical Center
Miami Beach, Florida, United States
AdventHealth Ocala
Ocala, Florida, United States
Northside Vascular
Cumming, Georgia, United States
Deaconess Research / Evansville Surgical Associates
Evansville, Indiana, United States
Indiana University
Indianapolis, Indiana, United States
Acadiana Vascular Clinic / Our Lady Lourdes Heart Hospital
Lafayette, Louisiana, United States
Maine Medical Center
Portland, Maine, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
McLaren Heart & Vascular
Bay City, Michigan, United States
Corewell Health
Grand Rapids, Michigan, United States
Abbott Northwestern
Minneapolis, Minnesota, United States
St. Luke's Hospital
Chesterfield, Missouri, United States
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
Hackensack University Medical Center
Hackensack, New Jersey, United States
New York University
New York, New York, United States
The Mount Sinai Hospital
New York, New York, United States
University of Rochester
Rochester, New York, United States
Bethesda North Hospital
Cincinnati, Ohio, United States
Providence Portland Medical Center-Hospital
Portland, Oregon, United States
St. Luke's University Hospital
Bethlehem, Pennsylvania, United States
UPMC Pinnacle
Harrisburg, Pennsylvania, United States
Lancaster General Hospital
Lancaster, Pennsylvania, United States
Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
Medical University of South Carolina (MUSC)
Charleston, South Carolina, United States
Cardiothoracic and Vascular Surgeons
Austin, Texas, United States
Memorial Hermann Southeast
Houston, Texas, United States
Houston Methodist Sugarland
Sugarland, Texas, United States
Sentara
Norfolk, Virginia, United States
Carilion Roanoke Memorial
Roanoke, Virginia, United States
Charleston Area Medical Center (CAMC)
Charleston, West Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SRM-2024-01
Identifier Type: -
Identifier Source: org_study_id